Blueprint Medicines today announced that Alexis Borisy, president and interim chief executive officer, will present a company overview at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco, California on Wednesday, January 15, 2014 at 10:00 am PT (1:00 pm ET). The overview will include the Company’s progress in developing its product engine and resulting pipeline of selective, genomically defined product candidates, as well as Blueprint’s 2014 goals and strategy for long-term growth.
Help employers find you! Check out all the jobs and post your resume.
